Haoran Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Haoran Xu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ao Ma
Department of Andrology Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School Nanjing Jiangsu China
1 shared publication - Beibei Zhang
Department of Urology & Andrology Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang China
1 shared publication - Chong Xie
Department of Urology and Andrology , Sir Run Run Shaw Hospital , Zhejiang University School of Medicine , Hangzhou , Zhejiang , China , zju.edu.cn
1 shared publication - Fei Sun
Institute of Reproductive Medicine, Medical School, Nantong University, Nantong, China
1 shared publication - Fuxing Zhang
Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang, China
1 shared publication Hongyi Wang
Department of Urology and Andrology , Sir Run Run Shaw Hospital , Zhejiang University School of Medicine , Hangzhou , Zhejiang , China , zju.edu.cn
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1) , 7629729
Pathogenic Variants in PET Complex Encoding Genes TDRD12 and EXD1 Impair piRNA Biogenesis and Cause Male Infertility
Background: Nonobstructive azoospermia (NOA), the most severe form of male infertility, has approximately 30% of its cases attributed to genetic factors. However, current genetic research only explains a small fraction of NOA cases. Methods: Here, 156 infertile Chinese patients diagnosed with idiopathic male infertility were recruited. Whole exome sequencing and subsequent bioinformatic analysis were performed to find candidate pathogenic variants. Sanger sequencing was used to validate the candidate variants. Quantitative reverse‐transcript PCR (RT‐qPCR) was performed to detect the mRNA expression of TDRD12 and related piRNA genes. Hematoxylin and eosin staining and immunofluorescence staining were performed on testicular sections obtained from patients′ biopsies. Intracytoplasmic sperm injection (ICSI) was applied for assisted fertilization. Additionally, small RNA sequencing was performed to identify the abnormalities of piRNA biogenesis. Results: We identified eight variants in PET (PIWI‐EXD1‐TDRD12) complex encoding genes TDRD12 and EXD1 from three NOA patients and one oligoasthenozoospermia patient. These variants, which were rare or absent in public human databases, were predicted to be deleterious. Notably, TDRD12 mRNA was absent in three NOA patients. Testicular histopathological analyses revealed that spermatogenesis was arrested at zygotene stage in patients carrying biallelic TDRD12 variants. Further immunofluorescence staining of L1ORF1p and small RNA sequencing revealed disruptions in piRNA biogenesis and subsequent derepression of retrotransposons. Further assisted reproduction outcomes showed that one of the individuals conceived successfully after ICSI. Conclusion: Overall, this study significantly expands the mutational phenotype of PET complex‐encoding genes and significantly advances our understanding of spermatogenic failure and male infertility. Our findings provide direct clinical and functional evidence that the function of the PET complex and piRNA biogenesis is highly conserved between humans and mice.
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1) , 7629729
Open AccessPathogenic Variants in PET Complex Encoding Genes TDRD12 and EXD1 Impair piRNA Biogenesis and Cause Male Infertility
Background: Nonobstructive azoospermia (NOA), the most severe form of male infertility, has approximately 30% of its cases attributed to genetic factors. However, current genetic research only explains a small fraction of NOA cases. Methods: Here, 156 infertile Chinese patients diagnosed with idiopathic male infertility were recruited. Whole exome sequencing and subsequent bioinformatic analysis were performed to find candidate pathogenic variants. Sanger sequencing was used to validate the candidate variants. Quantitative reverse‐transcript PCR (RT‐qPCR) was performed to detect the mRNA expression of TDRD12 and related piRNA genes. Hematoxylin and eosin staining and immunofluorescence staining were performed on testicular sections obtained from patients′ biopsies. Intracytoplasmic sperm injection (ICSI) was applied for assisted fertilization. Additionally, small RNA sequencing was performed to identify the abnormalities of piRNA biogenesis. Results: We identified eight variants in PET (PIWI‐EXD1‐TDRD12) complex encoding genes TDRD12 and EXD1 from three NOA patients and one oligoasthenozoospermia patient. These variants, which were rare or absent in public human databases, were predicted to be deleterious. Notably, TDRD12 mRNA was absent in three NOA patients. Testicular histopathological analyses revealed that spermatogenesis was arrested at zygotene stage in patients carrying biallelic TDRD12 variants. Further immunofluorescence staining of L1ORF1p and small RNA sequencing revealed disruptions in piRNA biogenesis and subsequent derepression of retrotransposons. Further assisted reproduction outcomes showed that one of the individuals conceived successfully after ICSI. Conclusion: Overall, this study significantly expands the mutational phenotype of PET complex‐encoding genes and significantly advances our understanding of spermatogenic failure and male infertility. Our findings provide direct clinical and functional evidence that the function of the PET complex and piRNA biogenesis is highly conserved between humans and mice.